Viewing Study NCT05688332

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2026-02-12 @ 1:43 AM
Study NCT ID: NCT05688332
Status: UNKNOWN
Last Update Posted: 2023-07-03
First Post: 2022-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients
Sponsor: University of Zambia
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus Type 2 Without Complication View
Keywords:

Keywords

Keyword Brief Keyword Text View
None voglibose View
None Metformin View
None Glibenclamide View
None Outcomes View